A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006014
Abstract: Key Points • Long-term romiplostim treatment is effective in children with primary ITP; serial bone marrow biopsy results showed no new safety concerns.• Romiplostim injections resulted in 8 AEs of neutralizing antibodies (romiplostim, n =… read more here.
Keywords: long term; safety; romiplostim; arm long ... See more keywords